Myxoma virus mutants for cancer treatment

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 35/76 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2652228

Myxoma viruses that are deficient in the activity of a Myxoma virus protein selected from the group consisting of M11L, M063, M 136, M-T4 and M-T7 are useful for treating cancer.

La présente invention concerne des virus du myxome qui sont déficients sur le plan de l'activité d'une de leurs protéines, choisie dans le groupe constitué par M11L, M063, M 136, M-T4 et M-T7. Les virus se révèlent utiles pour le traitement du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Myxoma virus mutants for cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Myxoma virus mutants for cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Myxoma virus mutants for cancer treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1811305

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.